Originality is insufficient to become the biggest constraint on the development of domestic medical devices

"In recent years, the level of innovation in domestic medical devices has improved, but we still lack the original innovative ability, which is the biggest bottleneck restricting the development of domestic medical devices." On January 31, the Chinese Medical Association Cardiovascular Branch, the People's Political Consultative Conference At the salon of "Innovative Development of Domestic Medical Devices" jointly sponsored by the newspaper, Huo Yong, member of the National Committee of the Chinese People's Political Consultative Conference and chairman of the Chinese Medical Association Cardiovascular Disease Branch, said that improving the level of innovation in domestic medical devices requires joint efforts of all parties, especially the doctors. .

Originality is insufficient to become the biggest constraint on the development of domestic medical devices

(From left to right: Huo Yong, Yu Guangyan, Dong Heyan, and Chi Hui, Qi Qibo)

Domestic medical device innovation doctors can not become visitors

Huo Yong introduced that in 2013, the number of cardiac interventions in China exceeded 450,000, and nearly 700,000 stents were used. More than 3/4 of the market has been occupied by domestic stents, but the original things are not in our hands. Although we may have some local or detailed improvements, such as the earliest stents we produced in the world with degradable drug coatings, there is no real whole original product.

Huo Yong pointed out that medical device innovation must come from doctors. Businesses may also have good ideas, but because he is not in the clinic, it is impossible to fully understand the needs of disease diagnosis and treatment, so the demand for equipment and the shortcomings are not as clear as doctors. But now Chinese doctors can't even see patients every day, they don't have time to innovate, they lack this kind of consciousness, and more importantly, they lack motivation, such as how to protect intellectual property rights, how to distribute benefits, and so on. "At present, the People's Hospital of Jiangsu Province has carried out useful explorations. They stipulate that doctors' innovations are owned by themselves, and 80% of the benefits are owned by themselves. At the national level, policies should also be introduced to encourage clinicians to participate in medical device research and development."

Domestically imported medical devices should be of the same quality

"China's medical device market is still dominated by imported products. Even domestically produced medical devices of superior quality and reasonable price are still relatively low in the number of public hospitals in the country." Yu Guangyan, member of the National Committee of the Chinese People's Political Consultative Conference and former dean of the Peking University Stomatological Hospital, said. There are objective reasons here. For example, some domestic medical devices are not good enough or have insufficient stability. Some manufacturers or sales departments have poor after-sales service, low user satisfaction, etc. Of course, there are also reasons, such as patients and their families. Imported medical devices are required, and medical personnel are not actively using domestic products.

"There are some problems in the national policy orientation. For example, the domestically-imported import price of the bidding price is different." Dong Heyan, member of the Liaoning Provincial Political Consultative Conference and chairman of the Liaoning Biomedical Materials Research and Development Center Co., Ltd., said that the current domestic cardiac stent and imported cardiac stent are in the technology. There is no difference in level, but in the bidding pricing, the average unit price of domestically produced brackets is 0.8 million yuan, and the average unit price of imported brackets is 16,000 yuan, which is 1 time difference; in orthopedic implant devices, the gap can reach 2 to 3 times. In addition, since the tender bidding is based on the historical lowest price, the original innovative products are lower than the imitation products. This kind of bidding pricing policy seriously dampens the enthusiasm of enterprise innovation. In the long run, it is not conducive to the healthy development of China's medical device industry.

Ear Health Care

Our mission: To protect the health of ear, throat and nose with medical frontier knowledge and technological innovation.
Our vision: Leader in several niche markets of Otolaryngology.
Our values: Change, Enterprising, Share

Electric Ear Washing Device, Ear Dryer, Medical Ear Syringe Pump, Ear Wax Removal Tool

Ningbo Jiamai Internet Technology CO., Ltd. , https://www.jmcuhyd.com